Dimensional Fund Advisors LP Has $45.70 Million Stake in Amedisys, Inc. (NASDAQ:AMED)

Dimensional Fund Advisors LP reduced its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 1.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 503,391 shares of the health services provider's stock after selling 5,894 shares during the quarter. Dimensional Fund Advisors LP owned about 1.54% of Amedisys worth $45,703,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in AMED. Blue Trust Inc. grew its holdings in Amedisys by 55.1% during the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after acquiring an additional 124 shares during the period. Xponance Inc. increased its stake in shares of Amedisys by 3.5% in the 4th quarter. Xponance Inc. now owns 4,349 shares of the health services provider's stock valued at $395,000 after acquiring an additional 148 shares during the last quarter. Inspire Investing LLC raised its position in shares of Amedisys by 3.6% in the 4th quarter. Inspire Investing LLC now owns 4,405 shares of the health services provider's stock valued at $400,000 after acquiring an additional 155 shares during the period. Gamco Investors INC. ET AL grew its holdings in Amedisys by 0.5% during the fourth quarter. Gamco Investors INC. ET AL now owns 30,334 shares of the health services provider's stock valued at $2,754,000 after purchasing an additional 159 shares during the period. Finally, Nisa Investment Advisors LLC grew its holdings in Amedisys by 1.2% during the fourth quarter. Nisa Investment Advisors LLC now owns 15,150 shares of the health services provider's stock valued at $1,375,000 after purchasing an additional 180 shares during the period. 94.36% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. Royal Bank of Canada restated an "outperform" rating and issued a $100.00 price target on shares of Amedisys in a report on Wednesday, April 16th. Stephens reissued an "equal weight" rating and issued a $101.00 price objective on shares of Amedisys in a research report on Tuesday, March 4th. Four analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $100.75.

Amedisys Stock Performance

NASDAQ AMED traded up $0.17 during trading on Friday, reaching $95.37. 46,040 shares of the company's stock were exchanged, compared to its average volume of 414,092. The stock has a market capitalization of $3.13 billion, a P/E ratio of 37.85, a PEG ratio of 1.78 and a beta of 0.96. The business has a 50 day moving average price of $92.91 and a 200-day moving average price of $91.74. Amedisys, Inc. has a fifty-two week low of $82.15 and a fifty-two week high of $98.95. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.13 by $0.12. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm had revenue of $594.78 million during the quarter, compared to the consensus estimate of $597.43 million. During the same period last year, the business posted $1.03 earnings per share. The business's revenue for the quarter was up 4.1% compared to the same quarter last year. Sell-side analysts forecast that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.